(Press-News.org) New Rochelle, NY, September 10, 2012-- Therapies for retinal diseases are expected to overtake those for glaucoma by 2014, reports Genetic Engineering & Biotechnology News (GEN). Because current retinal disease treatments only improve vision for six to eight weeks, there is a critical need for new remedies, according to a recent issue of GEN.
"As increasing numbers of baby-boomers continue to grow older, many will have to deal with eye diseases such as age-related macular degeneration," said John Sterling, Editor-in-Chief of GEN. "Some estimates put the current AMD and diabetic retinopathy drug segment of the market at $3 billion, and this is expected to increase to about $5 billion in two years."
Standard therapy has been Genentech's VEGF inhibitors Lucentis® and the off-label use of Avastin®. Regeneron, in collaboration with Bayer HealthCare, is challenging these drugs with a similar VEGF inhibitor, Eyela®. The FDA approved the drug last November for wet AMD.
In another approach, Acucela is in Phase II trials using visual cycle modulators to lighten the metabolic load on the retina by reducing the activity of the rod visual system. This protects the retina from light damage, improves retinal vasculature, and reduces the accumulation of A2E and other retinal-related toxic by-products.
GlaxoSmithKline has two drugs in Phase II trials for ocular therapy: darapladib, an oral Lp-PLA2 inhibitor for diabetic macular edema, and Votrient®, a multi-kinase angiogenesis inhibitor in eye drop form for AMD. Early-stage work also is under way for neovascular AMD, dry AMD, diabetic retinopathy, diabetic macula edema, uveitis, and glaucoma, as well as for technologies for drug delivery.
INFORMATION:
Other companies covered in the GEN article include Acucela, pSiveda, Sanofi, NeuroTech, QLT, Applied Genetic Technologies, RetroSense Therapeutics, Aerie Pharmaceuticals, Kowa Pharmaceuticals America, Novartis, Senju Pharmaceutical, Can-Fite Biopharma, Inotek Pharmaceuticals, Otsuka Pharmaceutical, and Santen Pharmaceutical.
For a copy of the September 1 issue of GEN, please call (914) 740-2146, or email: pbartell@genengnews.com
Genetic Engineering & Biotechnology News, which is published 21 times a year by Mary Ann Liebert, Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Translational Medicine.
GEN reports on ocular therapeutics targeting the retina
2012-09-11
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Pain drug can kill resistant tuberculosis
2012-09-11
NEW YORK (September 10, 2012) -- An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory -- a feat few currently approved TB drugs can do, and resistance to those is spreading.
Their findings, published online by the journal PNAS, point to a potential new therapy for the more than 500,000 people worldwide whose TB has become resistant to standard drug treatments. But ...
Rhode Island Hospital study shows wine has more cardiovascular benefits than vodka
2012-09-11
PROVIDENCE, R.I. – The next time you call someone a drunken pig, remember this study. Rhode Island Hospital researcher Frank Sellke, M.D., chief of cardiothoracic surgery at Rhode Island and The Miriam hospitals, and his colleagues studied the effects of red wine and vodka on pigs with high cholesterol and found that the pigs with a penchant for pinot noir fared better than their vodka swilling swine counterparts. The paper is published in the September issue of the journal Circulation.
"There has been previous research touting the benefits of moderate consumption of ...
Ants have an exceptionally 'hi-def' sense of smell
2012-09-11
Ants have four to five times more odor receptors than most other insects, a team of researchers have discovered.
The research team, led by Lawrence Zwiebel at Vanderbilt, recently completed the first full map of olfactory system that provides ants with their sense of taste and smell. They found the industrious insects have genes that make about 400 distinct odorant receptors, special proteins that detect different odors. By comparison, silk moths have 52, fruit flies have 61, mosquitoes range from 74 to 158 and honeybees have 174.
"The most exciting moment for me was ...
Researchers find 2 gene mutations drive adrenal cancer
2012-09-11
This press release is available in Portuguese.
ANN ARBOR, Mich. — Two different genetic mutations cooperate to induce adrenal cancer, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center and University of Sao Paulo in Brazil.
The finding provides new clues to this rare and deadly cancer type, and researchers hope it will lead to better treatments by targeting both mutations.
About 600 Americans are diagnosed with adrenal cancer per year. It is typically diagnosed in late stages when there is nearly no chance of survival ...
CWRU nurse researchers find effort takes its toll on unpaid family caregivers
2012-09-11
According to AARP, the annual cost of unpaid elder caregiving – work that falls mainly on the backs of family members – runs about $450 billion.
While some companies document the physical and emotional toll that the workplace takes on their employees, exactly how draining caregiving might be has never really been measured.
So Case Western Reserve University nurse researchers studied it.
"Without knowing the impact of effort, we have two vulnerable people at risk for health issues—the caregiver and the care receiver," said Evanne Juratovac, assistant professor at ...
'Civilian cyber-warriors' not driven by patriotism
2012-09-11
EAST LANSING, Mich. -- People who commit cyber-attacks against the government also tend to download music illegally and participate in physical protests. Surprisingly, however, they don't appear to be acting out of some sense of national pride or patriotism.
Those are some of the findings to emerge from a Michigan State University study that for the first time begins to paint a profile of "civilian cyber-warriors," or people who engage in attacks against domestic or foreign governments. Cybercrimes pose a huge societal risk and have become a hot issue globally, yet little ...
Study ties forest 'greenness' in western US to snowpack extent
2012-09-11
Results of a new study tie forest "greenness" in the western United States to fluctuating year-to-year snowpack extent.
The results show that mid-elevation mountain ecosystems are the most sensitive to rising temperatures and to changes in precipitation and snowmelt.
University of Colorado-Boulder scientist Noah Molotch and colleagues used satellite images and ground measurements to identify the threshold at which mid-level forests sustained by moisture change to higher-elevation forests sustained by sunlight.
A paper reporting the results was published yesterday ...
NASA catches Tropical Storm Leslie and Hurricane Michael in the Atlantic
2012-09-11
Satellite images from two NASA satellites were combined to create a full picture of Tropical Storm Leslie and Hurricane Michael spinning in the Atlantic Ocean. Imagery from NASA's Aqua and Terra satellites showed Leslie now past Bermuda and Michael in the north central Atlantic, and Leslie is much larger than the smaller, more powerful Michael.
Images of each storm were taken by the Moderate Resolution Imaging Spectroradiometer, or MODIS instrument that flies onboard both the Aqua and Terra satellites. Both satellites captured images of both storms on Sept. 7 and Sept. ...
'Humanized' mice developed at OHSU enable malaria research breakthrough at Seattle BioMed
2012-09-11
PORTLAND, Ore. — A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.
The study findings are published online in the Journal of Clinical Investigation. Study photos were selected to appear in "Scientific Show Stoppers" on the JCI blog.
Plasmodium falciparum, one of two human-specific malaria parasites, is a global health crisis, causing more than ...
Mushroom-derived compound lengthens survival in dogs with cancer, Penn Vet study finds
2012-09-11
PHILADELPHIA — Dogs with hemangiosarcoma that were treated with a compound derived from the Coriolus versicolor mushroom had the longest survival times ever reported for dogs with the disease. These promising findings offer hope that the compound may one day offer cancer patients — human and canine alike — a viable alternative or complementary treatment to traditional chemotherapies.
The study was conducted by two University of Pennsylvania School of Veterinary Medicine faculty. Dorothy Cimino Brown is professor and chair of the Department of Clinical Studies and director ...